Cite
MLA Citation
Alberto A. Chiappori et al.. “A Randomized Phase II Study of Linsitinib (OSI‐906) Versus Topotecan in Patients With Relapsed Small‐Cell Lung Cancer.” Oncologist, vol. 21, 2016, pp. 1163–1164e. http://access.bl.uk/ark:/81055/vdc_100054376310.0x000030